FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029385844> ?p ?o ?g. }

• W2029385844 endingPage "127" @default.
• W2029385844 startingPage "118" @default.
• W2029385844 abstract "We report the characteristics of three cell lines (designated, SNU-80, SNU-373 and SNU-790), which were established from two papillary carcinomas and one anaplastic carcinoma obtained from three Korean thyroid carcinoma patients. All cell lines grow as adherent cells. Electron microscopy characteristically showed cytoplasmic invaginations of nuclei and intranuclear cytoplasmic inclusions. SNU-80 and SNU-790 cells showed a positive reaction to anti-cytokeratin antibody, and SNU-790 cells positivity for CK-19. All lines were free of mycoplasma or bacteria and were proven unique by DNA fingerprinting analysis. The p15 and p16 genes are deleted in the SNU-790 line. Mutations of the p53 gene were found in two lines (SNU-80 and SNU-373), but no mutations in the RET or MEN1 genes were observed. Mutations of the BRAF gene were found in the SNU-80 (G468R) and the SNU-790 (V599E) cell lines, but no mutations in the K-ras gene were present. SNU-80 and SNU-790 cells showed a positive reaction to anti-cytokeratin antibody, and no evidence of the production of thyroglobulin or calcitonin was observed. The cell lines were unable to trap radioactive iodine but did not contain TSH receptor. In addition, we investigated the mRNA expression levels of Tg, TSHR, TTF-1, PAX-8, NIS, IL-6, and LIF, and of the alpha, beta and gamma retinoic acid receptors in these cell lines. IL-6 was down-regulated in all three cell lines by all-trans-retinoic acid treatment. RAR-alpha was expressed but RAR-beta was not expressed in the three cell lines, and RAR-gamma was not expressed in SNU-790. Interestingly, RAR-beta (SNU-80 and SNU-373) and RAR-gamma (SNU-790) was up-regulated by all-trans-retinoic acid treatment. We believe that these well-characterized thyroid carcinoma cell lines may be useful tools for investigations on the biological characteristics of thyroid carcinoma, particularly for investigations related to gene alterations, especially of the BRAF gene. These cell lines may also be useful for redifferentiation therapy studies on thyroid carcinoma using all-trans-retinoic acid." @default.
• W2029385844 created "2016-06-24" @default.
• W2029385844 creator A5004620529 @default.
• W2029385844 creator A5006916333 @default.
• W2029385844 creator A5009075091 @default.
• W2029385844 creator A5013226696 @default.
• W2029385844 creator A5019048136 @default.
• W2029385844 creator A5023025574 @default.
• W2029385844 creator A5032209991 @default.
• W2029385844 creator A5035258595 @default.
• W2029385844 creator A5036124455 @default.
• W2029385844 creator A5040645776 @default.
• W2029385844 creator A5065522255 @default.
• W2029385844 creator A5065930316 @default.
• W2029385844 creator A5085614043 @default.
• W2029385844 date "2007-01-01" @default.
• W2029385844 modified "2023-10-18" @default.
• W2029385844 title "Establishment and characterization of cell lines from three human thyroid carcinomas: Responses to all-trans-retinoic acid and mutations in the BRAF gene" @default.
• W2029385844 cites W178326966 @default.
• W2029385844 cites W1968185708 @default.
• W2029385844 cites W1981090278 @default.
• W2029385844 cites W1987817896 @default.
• W2029385844 cites W1994486169 @default.
• W2029385844 cites W1994696540 @default.
• W2029385844 cites W2001258296 @default.
• W2029385844 cites W2009573813 @default.
• W2029385844 cites W2017981742 @default.
• W2029385844 cites W2018404994 @default.
• W2029385844 cites W2029152630 @default.
• W2029385844 cites W2035341020 @default.
• W2029385844 cites W2042078307 @default.
• W2029385844 cites W2042316019 @default.
• W2029385844 cites W2044232259 @default.
• W2029385844 cites W2083842309 @default.
• W2029385844 cites W2092200570 @default.
• W2029385844 cites W2100378386 @default.
• W2029385844 cites W2135687675 @default.
• W2029385844 cites W2157715173 @default.
• W2029385844 cites W2168261275 @default.
• W2029385844 cites W2169250920 @default.
• W2029385844 cites W2171003891 @default.
• W2029385844 cites W2171616698 @default.
• W2029385844 cites W2171913143 @default.
• W2029385844 cites W4256038467 @default.
• W2029385844 doi "https://doi.org/10.1016/j.mce.2006.10.017" @default.
• W2029385844 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17134824" @default.
• W2029385844 hasPublicationYear "2007" @default.
• W2029385844 type Work @default.
• W2029385844 sameAs 2029385844 @default.
• W2029385844 citedByCount "22" @default.
• W2029385844 countsByYear W20293858442012 @default.
• W2029385844 countsByYear W20293858442013 @default.
• W2029385844 countsByYear W20293858442014 @default.
• W2029385844 countsByYear W20293858442016 @default.
• W2029385844 countsByYear W20293858442017 @default.
• W2029385844 countsByYear W20293858442018 @default.
• W2029385844 countsByYear W20293858442021 @default.
• W2029385844 countsByYear W20293858442022 @default.
• W2029385844 countsByYear W20293858442023 @default.
• W2029385844 crossrefType "journal-article" @default.
• W2029385844 hasAuthorship W2029385844A5004620529 @default.
• W2029385844 hasAuthorship W2029385844A5006916333 @default.
• W2029385844 hasAuthorship W2029385844A5009075091 @default.
• W2029385844 hasAuthorship W2029385844A5013226696 @default.
• W2029385844 hasAuthorship W2029385844A5019048136 @default.
• W2029385844 hasAuthorship W2029385844A5023025574 @default.
• W2029385844 hasAuthorship W2029385844A5032209991 @default.
• W2029385844 hasAuthorship W2029385844A5035258595 @default.
• W2029385844 hasAuthorship W2029385844A5036124455 @default.
• W2029385844 hasAuthorship W2029385844A5040645776 @default.
• W2029385844 hasAuthorship W2029385844A5065522255 @default.
• W2029385844 hasAuthorship W2029385844A5065930316 @default.
• W2029385844 hasAuthorship W2029385844A5085614043 @default.
• W2029385844 hasConcept C134018914 @default.
• W2029385844 hasConcept C153911025 @default.
• W2029385844 hasConcept C2781121885 @default.
• W2029385844 hasConcept C2993294228 @default.
• W2029385844 hasConcept C502942594 @default.
• W2029385844 hasConcept C526584372 @default.
• W2029385844 hasConcept C54355233 @default.
• W2029385844 hasConcept C81885089 @default.
• W2029385844 hasConcept C86803240 @default.
• W2029385844 hasConceptScore W2029385844C134018914 @default.
• W2029385844 hasConceptScore W2029385844C153911025 @default.
• W2029385844 hasConceptScore W2029385844C2781121885 @default.
• W2029385844 hasConceptScore W2029385844C2993294228 @default.
• W2029385844 hasConceptScore W2029385844C502942594 @default.
• W2029385844 hasConceptScore W2029385844C526584372 @default.
• W2029385844 hasConceptScore W2029385844C54355233 @default.
• W2029385844 hasConceptScore W2029385844C81885089 @default.
• W2029385844 hasConceptScore W2029385844C86803240 @default.
• W2029385844 hasIssue "1-2" @default.
• W2029385844 hasLocation W20293858441 @default.
• W2029385844 hasLocation W20293858442 @default.
• W2029385844 hasOpenAccess W2029385844 @default.
• W2029385844 hasPrimaryLocation W20293858441 @default.
• W2029385844 hasRelatedWork W2005534677 @default.
• W2029385844 hasRelatedWork W2006957921 @default.

• next